Valvular & structural heart disease
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASessment and TReatment In Decompensated Aortic Stenosis (ASTRID-AS) study)- A pilot study
Authors' conclusion
A dedicated pathway for ADAS that shortens time to TAVI demonstrated reduced hospital LoS without compromising patient safety and a trend towards improving clinical outcomes.
Study context
- Population
- Patients with acute decompensated AS referred for transcatheter aortic valve implantation (TAVI)
- Participants
- 25 vs 58
- Exposure
- ASTRID-AS pathway vs conventional pathway
- ASTRID-ASn = 25
- Conventionaln = 58reference
- Outcome
- Hospital length of stay (LoS)
Methodological detailsprospective, open label, cluster
- Prospective
- Open label
- Cluster
Main finding
As reported in the abstract
Hospital length of stay
P < 0.001
- Bed days saved per patient with ASTRID-AS
- 13.4
Observational data: associations, not effects.
Further findings
Time to TAVI
P < 0.001
- Secondary safety endpoint: death or acute kidney injury (AKI) · 30 days post-TAVI
- P = 0.093
Bed days saved
- Bed days saved per patient with ASTRID-AS pathway
- 13.4
Procedural complications
- Similar between the two cohorts
Safety
Procedural complications
- Similar between the two cohorts
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study. Eur Heart J Qual Care Clin Outcomes. Published 15 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →